126 related articles for article (PubMed ID: 33592500)
1. A Proteomic Approach to Understand the Clinical Significance of Acute Myeloid Leukemia-Derived Extracellular Vesicles Reflecting Essential Characteristics of Leukemia.
Kang KW; Kim H; Hur W; Jung JH; Jeong SJ; Shin H; Seo D; Jeong H; Choi B; Hong S; Kim HK; Choi Y; Park JH; Lee KY; Kim KP; Park Y
Mol Cell Proteomics; 2021; 20():100017. PubMed ID: 33592500
[TBL] [Abstract][Full Text] [Related]
2. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
[TBL] [Abstract][Full Text] [Related]
3. Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling.
Tohumeken S; Baur R; Böttcher M; Stoll A; Loschinski R; Panagiotidis K; Braun M; Saul D; Völkl S; Baur AS; Bruns H; Mackensen A; Jitschin R; Mougiakakos D
Cancer Res; 2020 Sep; 80(17):3663-3676. PubMed ID: 32605996
[TBL] [Abstract][Full Text] [Related]
4. Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles.
Binder HM; Maeding N; Wolf M; Cronemberger Andrade A; Vari B; Krisch L; Gomes FG; Blöchl C; Muigg K; Poupardin R; Raninger AM; Heuser T; Obermayer A; Ebner-Peking P; Pleyer L; Greil R; Huber CG; Schallmoser K; Strunk D
Cells; 2021 Nov; 10(12):. PubMed ID: 34943829
[TBL] [Abstract][Full Text] [Related]
5. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
Fang Z; Wang X; Wu J; Xiao R; Liu J
Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
[TBL] [Abstract][Full Text] [Related]
6. Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes.
Kargar-Sichani Y; Mohammadi MH; Amiri V; Barzegar M; Keshavarz A; Bashash D; Farsani MA
Arch Med Res; 2023 Feb; 54(2):95-104. PubMed ID: 36717322
[TBL] [Abstract][Full Text] [Related]
7. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
8. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
9. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
10. Disease dynamics in patients with acute myeloid leukemia: new biomarkers.
Tzoran I; Rebibo-Sabbah A; Brenner B; Aharon A
Exp Hematol; 2015 Nov; 43(11):936-43. PubMed ID: 26232698
[TBL] [Abstract][Full Text] [Related]
11. Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.
Kaźmierczak M; Luczak M; Lewandowski K; Handschuh L; Czyż A; Jarmuż M; Gniot M; Michalak M; Figlerowicz M; Komarnicki M
Med Oncol; 2013 Dec; 30(4):725. PubMed ID: 24085543
[TBL] [Abstract][Full Text] [Related]
12. Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.
Cao T; Ye Y; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Medicine (Baltimore); 2019 Jun; 98(23):e15948. PubMed ID: 31169718
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics.
Kontopoulou E; Strachan S; Reinhardt K; Kunz F; Walter C; Walkenfort B; Jastrow H; Hasenberg M; Giebel B; von Neuhoff N; Reinhardt D; Thakur BK
Ann Hematol; 2020 Mar; 99(3):459-475. PubMed ID: 31932899
[TBL] [Abstract][Full Text] [Related]
14. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia.
Wang J; Lai ZL; Chen XY; Li DY; Zhang YY; Ma W; Chu YT; Shi FQ; Yang L; Hou L
Chin J Integr Med; 2016 Jun; 22(6):438-44. PubMed ID: 26666761
[TBL] [Abstract][Full Text] [Related]
15. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.
Strassberger V; Gutbrodt KL; Krall N; Roesli C; Takizawa H; Manz MG; Fugmann T; Neri D
J Proteomics; 2014 Mar; 99():138-51. PubMed ID: 24487095
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD157 in AML using a novel, Fc-engineered antibody construct.
Krupka C; Lichtenegger FS; Köhnke T; Bögeholz J; Bücklein V; Roiss M; Altmann T; Do TU; Dusek R; Wilson K; Bisht A; Terrett J; Aud D; Pombo-Villar E; Rohlff C; Hiddemann W; Subklewe M
Oncotarget; 2017 May; 8(22):35707-35717. PubMed ID: 28415689
[TBL] [Abstract][Full Text] [Related]
19. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
